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AbstrAct
Objective To evaluate the association of cigarette 
smoking and right ventricular (RV) systolic and diastolic 
functions in a population- based cohort of individuals at 
middle age.
Methods This cross- sectional study included participants 
who answered the smoking questionnaire and 
underwent echocardiography at the Coronary Artery Risk 
Development in Young Adulthood year 25 examination. 
RV systolic function was assessed by echocardiographic- 
derived tricuspid annular plane systolic excursion (TAPSE) 
and by right ventricular peak systolic velocity (RVS’), 
while RV diastolic function was evaluated by early right 
ventricular tissue velocity (RVE’). Multivariable linear 
regression models assessed the relationship of smoking 
with RV function, adjusting for age, sex, race, body mass 
index, systolic blood pressure, total cholesterol, high- 
density lipoprotein (HDL) cholesterol, diabetes mellitus, 
alcohol consumption, pulmonary function, left ventricular 
systolic and diastolic function and coronary artery calcium 
score.
Results A total of 3424 participants were included. The 
mean age was 50±4 years; 57% were female; and 53% 
were black. There were 2106 (61%) never smokers, 
750 (22%) former smokers and 589 (17%) current 
smokers. In the multivariable analysis, current smokers 
had significantly lower TAPSE (β=−0.082, SE=0.031, 
p=0.008), RVS’ (β=−0.343, SE=0.156, p=0.028) and RVE’ 
(β=−0.715, SE=0.195, p<0.001) compared with never 
smokers. Former smokers had a significantly lower RVE’ 
compared with never smokers (β=−0.414, SE=0.162, 
p=0.011), whereas no significant difference in RV systolic 
function was found between former smokers and never 
smokers.
Conclusions In a large multicenter community- based 
biracial cohort of middle- aged individuals, smoking was 
independently related to both worse RV systolic and 
diastolic functions.
IntROduCtIOn
Smoking is a major cardiovascular risk factor. 
The relationship between cigarette consump-
tion and cardiovascular disease (CVD) is 
long- time recognised, with early description 
back to 1964 in the very first surgeon gener-
al’s report.1 After more than half of a century, 
strong evidence supports the association 
between tobacco use and multiple cardiovas-
cular conditions, including coronary heart 
disease and stroke.2 Several mechanisms 
have been linked to smoking- related CVD, 
such as atherogenesis, platelet dysfunction, 
prothrombotic and antifibrinolytic effects, 
vasomotor dysfunction, inflammation and 
modification of lipid profile.3
Despite extensive epidemiological, clin-
ical and experimental data explaining the 
association of cigarette consumption and 
harmful consequences on cardiovascular 
function, many aspects of this relationship 
remain unclear, in particular, the effect of 
smoking on right ventricular (RV) function. 
The right ventricle is potentially affected 
in smokers who develop severe chronic 
obstructive pulmonary disease (COPD) 
and pulmonary hypertension, although 
other pathways may be involved, such as left 
ventricular (LV) dysfunction, subclinical 
atherosclerosis and chronic systemic inflam-
matory response.
Thus, the aim of this study was to evaluate 
the association of cigarette smoking with RV 
Key questions
What is already known about this subject?
 ► Smoking is a major cardiovascular risk factor.
What does this study add?
 ► Smoking is independently related to both worse 
right ventricular systolic and diastolic functions.
How might this impact on clinical practice?
 ► Stopping smoking might prevent right heart failure.
Protected by copyright.
 o
n
 April 15, 2020 at M
edical School Library University of M
ass.
http://openheart.bmj.com/
O
pen Heart: first published as 10.1136/openhrt-2020-001270 on 8 M
arch 2020. Downloaded from
 
Open Heart
2 Moreira HT, et al. Open Heart 2020;7:e001270. doi:10.1136/openhrt-2020-001270
systolic and diastolic functions in a population- based 
cohort of individuals at middle age.
MetHOds
study participants
The Coronary Artery Risk Development in Young Adult-
hood (CARDIA) study is a prospective community- based 
cohort enrolling initially 5115 black and white men and 
women aged 18–30 years in 1985–1986 free of known 
CVD, originally designed to investigate the development 
of CVD and their risk factors. Participants were recruited 
and examined at four field centres: Birmingham, 
Alabama; Chicago, Illinois; Minneapolis, Minnesota; 
and Oakland, California. Of 3498 participants (72% of 
surviving cohort) attending the year 25 (2010–2011) 
examination, 3445 (98.5%) answered the smoking ques-
tionnaire. Of those who answered the smoking question-
naire, 3424 also underwent echocardiography and were 
included in this present investigation.
smoking
Smoking status was ascertained by structured question-
naires. Current smokers were those who smoked more 
than five cigarettes per day for more than 3 months, while 
former smokers were those who had previously smoked 
more than five cigarettes per day for more than 3 months 
but were not currently smoking. Never smokers were 
those who had never smoked or who had smoked more 
than five cigarettes/day for more than 3 months in their 
lifetime. For current smokers, cigarette consumption 
intensity and duration were assessed as number of cigar-
retes smoked/day, total years of smoking regularly and 
cigarrete pack- years (packs/day×years smoking).
Clinical measurements
Participants were asked to avoid smoking or engaging 
in heavy physical activity for at least 2 hours before each 
examination and to fast for 12 hours.4 Systolic blood 
pressure (SBP) and diastolic blood pressure (DBP) were 
obtained 5 min after the participant had been seated, 
and the second and third readings were averaged. Blood 
samples were drawn to measure lipid profile, glucose 
level and glycated haemoglobin. Diabetes mellitus (DM) 
was defined as a fasting plasma glucose of ≥126 mg/dL, 
2 hours postload glucose of ≥200 mg/dL during a 75 g 
oral glucose tolerance test, glycated haemoglobin of 
≥6.5% or use of antidiabetes medication. Average daily 
consumption of alcohol was calculated from question-
naire information. Educational status was verified using 
standardised questionnaire and measured as years of 
education.
Pulmonary function testing was performed at CARDIA 
year 20 examination (2005–2006) using a dry rolling- seal 
OMI spirometer (Viasys Corporation, Loma Linda, Cali-
fornia, USA), as previously described.5 Forced expiratory 
volume in one second (FEV1) and forced vital capacity 
were measured according to standard spirometer 
procedures as recommended by the American Thoracic 
Society.6
Coronary artery calcium (CAC) score was measured 
from CT by using 64- channel multidetector scanners 
(Siemens, Erlangen, Germany, or GE Healthcare, 
Milwaukee, Wisconsin, USA) at year 25 examination, as 
detailed elsewhere.7
echocardiography
The echocardiographic protocol at the CARDIA year 25 
examination has been previously published.8 9 Briefly, 
transthoracic echocardiography was performed using 
an Artida ultrasound system (Toshiba Medical Systems, 
Tokyo, Japan), with phased- array transducers from 1.8 to 
4.2 MHz, following a standardised acquisition protocol. 
Technicians at each of the four field centres were 
centrally trained and certified. Parasternal longitudinal 
and short- axis views, as well as apical four- chamber and 
two- chamber views, were acquired. Measurements of RV 
function were performed at the apical four- chamber view 
focused on the right ventricle.
RV systolic function was assessed using tissue Doppler- 
derived tricuspid annular peak systolic velocity (right 
ventricular peak systolic velocity (RVS’)). The higher 
the RVS’, the better the RV systolic function. RV systolic 
function was also examined by using M- mode- derived 
tricuspid annular plane systolic excursion (TAPSE). The 
higher the TAPSE, the better the RV systolic function. 
RV diastolic function was evaluated by tissue Doppler- 
derived early diastolic tricuspid annular velocity (right 
ventricular early diastolic velocity (RVE’)). The higher 
the RVE’, the better the RV diastolic function. Cut- off 
values for defining RV systolic and diastolic dysfunctions 
were based on the latest guidelines from the American 
Society of Echocardiography as follows: RVS’<0.95 cm/s, 
TAPSE <17 mm/s and RVE’<7.8 cm/s.10
LV volumes and LV ejection fraction were estimated by 
biplane Simpson’s method. LV mass was calculated from 
M- mode measures using the cube formula.10 . LV longi-
tudinal strain, a measure of myocardial systolic function, 
was derived from speckle tracking analysis, as previously 
described.9 LV diastolic function was assessed by tissue- 
Doppler derived LV lateral e’. Pulsed Doppler- derived 
E- wave from mitral inflow was used to derive the E/e’ 
ratio, an index of LV filling pressure. Left atrial volume 
was calculated using the disk summation algorithm in 
the apical four- chamber view. Pulmonary artery systolic 
pressure (PASP) was derived from tricuspid regurgitant 
jet velocity using the modified Bernoulli equation, as 
published elsewhere.11
statistical analysis
Continuous data are reported as mean±SD if normally 
distributed, and median (IQR) if non- normally distrib-
uted. Histograms and skewness test were performed to 
assess the normality of the data. The primary cigarette 
consumption exposure variable in this study was smoking 
status. In those who were current smokers at year 25, 
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smoking intensity (number of cigarettes smoked per 
day), smoking duration (years of smoking regularly alto-
gether) and cumulative smoking exposure (cigarette 
pack- years) were analysed by dividing into tertiles for 
an exploratory analysis. Differences in baseline charac-
teristics across smoking status were evaluated by test for 
trend across ordered groups,12 Student t- test and χ2 test 
as appropriate. Multivariable linear regression models 
assessed the relationship of smoking status, smoking 
intensity, smoking duration and cumulative smoking 
exposure (independent variables) with RV systolic and 
diastolic functions (dependent variables), adjusting for 
age, sex, race, educational status, body mass index (BMI), 
SBP, total cholesterol, HDL cholesterol, DM, antihyper-
tensive and lipid- lowering medications, alcohol consump-
tion, FEV1, LV ejection fraction, LV E/e’ ratio and CAC. 
Interaction terms were used to verify whether the associa-
tion of smoking status with RV function is modified by sex 
and race. The variance inflation factor was used to test 
collinearity, with a mean value of 1.35, reflecting absence 
of significant multicollinearity. All tests were two- tailed. 
Values of p<0.05 were considered significant. All statis-
tical analyses were performed with STATA V.15.1.
Patient involvement
Participants were not involved in setting the research ques-
tion or the outcome measures, nor were they involved in 
developing plans for recruitment, design or implemen-
tation of the study. No patients were asked for advice 
on interpretation or writing up of results. Results from 
the CARDIA study were disseminated to the community, 
including study participants, via newsletters and website 
(https://www. cardia. dopm. uab. edu).
Results
A total of 3424 participants were included, with a mean 
age of 50±4 years; 57% were female; and 53% were black. 
Never smokers, former smokers and current smokers 
were 2106 (61%), 750 (22%), 589 (17%) individuals, 
respectively. Current smokers reported a median smoking 
intensity of 10 (IQR: 5–15) cigarettes/day, and a median 
duration of 29 (IQR: 20–34) years of smoking regularly, 
while median cumulative cigarette smoking exposure was 
9.0 (IQR: 4.5–13.5) pack- years.
TAPSE, RVS’ and RVE’ were obtained in 3177 (93%), 
3262 (95%) and 3282 (96%) participants included in 
this study. TAPSE, RVS’ and RVE’ were not feasible in 
247 (7%), 162 (5%) and 182 (4%) individuals due to 
poor image quality. Mean TAPSE, RVS’ and RVE’ were 
2.5±0.5 cm, 13.4±2.5 cm/s and 12.4±3.2 cm/s, respec-
tively. Reduced RVS’, TAPSE and RVE’ were found in 119 
(3.4%), 94 (2.5%) and 75 (2.2%) participants, respec-
tively. Mean LV ejection fraction and LV lateral e’ were 
61%±7% and 11.8±2.8 cm/s, respectively. Mean PASP was 
31±6 mm Hg, measured in 1283 (38%) participants who 
had a significant tricuspid regurgitant jet.
Participants’ characteristics according to smoking 
status are presented in table 1. The proportions of women 
in never smoker, former smoker and current smoker 
status were 57%, 60% and 51% (p=0.007), respectively. 
A majority of current smokers were black, 62%, while the 
proportions of black race in never smoker and former 
smoker status were 46% and 36%, respectively (p<0.001).
RVS’ was significantly worse in current smokers 
(13.2±2.5 cm/s) compared with never smokers (13.5±2.5 
cm/s), but not significantly different between current 
smokers and former smokers. When assessed by TAPSE, 
RV systolic function was also significantly worse in 
current smokers (2.45±0.5 cm), in comparison with 
both never smokers (2.56±0.53 cm) and former smokers 
(2.57±0.53 cm), p<0.001 for both comparisons, but not 
significantly different between never and former smokers. 
RV diastolic function evaluated by RVE’ was significantly 
worse in current smokers (11.8±3.0 cm/s) in comparison 
with both never smokers (12.7±3.3 cm/s) (p<0.001), and 
former smokers (12.3±3.0 cm/s) (p=0.027). RVE’ was 
significantly lower in formers smokers in comparison 
with never smokers (12.7±3.3 cm/s) (p=0.024).
Educational status decreased, while daily alcohol 
consumption and proportion of positive CAC score 
increased from those who had never smoked towards 
current smokers. Current smokers had higher SBP, 
higher DBP and lower FEV1 compared with both never 
smokers and former smokers. BMI was significantly lower 
in current smokers in comparison with those who had 
never smoked, while HDL cholesterol was significantly 
lower in current smokers in comparison with former 
smokers.
Multivariable analysis
In the multivariable analysis, current smokers showed 
a reduced RVS’ (β=−0.343, SE=0.156, p=0.028) and 
a reduced TAPSE (β=−0.082, SE=0.031, p=0.008) in 
comparison with never smokers, independently of age, 
sex, race, educational status, traditional cardiovascular 
risk factors, alcohol consumption, pulmonary function, 
LV systolic and diastolic function and CAC score (tables 2 
and 3).
Compared with never smokers, both current smokers 
and former smokers had significantly lower RVE’ in the 
multivariable model (β=−0.715, SE=0.195, p<0.001, for 
former smokers, and β=−0.414, SE=0.162, p=0.011, for 
current smokers) (table 4).
Detailed descriptions of the models are present in 
online supplementary tables 1-3.
Race and sex showed no significant interaction with the 
association of smoking status and RV systolic and diastolic 
function.
exploratory analysis: smoking intensity, duration and pack-
years
Smoking duration was characterised as years of smoking 
regularly by tertile: first tertile=less than 26 years; second 
tertile=from 26 to 32 years; and third tertile=equal or 
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Table 1 Characteristics of the participants according to smoking status
Smoking status
N F C Comparisons between groups†
n=2106 n=750 n=589 P value* N versus F N versus C
F versus 
C
Demographic and clinical parameters
  Age (years) 50.1±3.6 50.9±3.5 49.6±3.7 <0.001 <0.001 0.027 <0.001
  Female 57% 60% 51% 0.007
  Black race 46% 36% 62% <0.001
  Body mass index (kg/m2) 30±7 30±7 29±7 0.028 1.000 0.039 0.052
  Education (years) 16 (14–18) 15 (13–16) 13 (12–15) <0.001 <0.001 <0.001 <0.001
  Systolic blood pressure (mm Hg) 119±16 118±15 123±17 <0.001 0.838 <0.001 <0.001
  Diastolic blood pressure (mm Hg) 74±11 74±11 77±12 <0.001 1.000 <0.001 <0.001
  On antihypertensive medication (%) 26 27 32 <0.001
  Total cholesterol (mg/dL) 192±36 193±37 193±41 0.781
  HDL cholesterol (m/dL) 58±17 59±18 56±20 0.017 0.194 0.281 0.013
  On lipid- lowering medication (%) 15 17 16 0.331
  Diabetes mellitus (%) 13 13 17 0.098
  Alcohol consumption/day (mL) 2 (0–12) 5 (0–17) 8 (0–27) <0.001 <0.001 <0.001 <0.001
Echocardiography
  RVS' (cm/s) 13.5±2.5 13.5±2.6 13.2±2.5 0.038 0.768 0.031 0.112
  TAPSE (mm) 2.56±0.50 2.57±0.53 2.45±0.50 <0.001 1.000 <0.001 <0.001
  RVe' (cm/s) 12.7±3.3 12.3±3.0 11.8±3.0 <0.001 0.024 <0.001 0.027
  LV end- diastolic volume (mL) 112±31 110±31 113±30 0.192
  LV end- systolic volume (mL) 44±18 43±20 45±18 0.169
  LV ejection fraction (%) 61±7 62±7 61±7 0.092
  LV mass index (g/m2) 82±21 84±21 89±22 <0.001 0.021 <0.001 <0.001
  LV longitudinal strain (%) −15.1±2.4 −15.3±2.4 −14.7±2.3 <0.001 0.489 0.001 <0.001
  E wave (cm/s) 79±16 78±17 79±17 0.465
  LV lateral wall e' (cm/s) 11.9±2.9 11.7±2.8 11.2–2.8 <0.001 0.656 <0.001 0.004
  LV E/e' 7.0±2.3 7.0±2.3 7.6±2.9 <0.001 1.000 <0.001 <0.001
  LA volume index (mL/m2) 24.5±6.9 24.5±7.0 25.0±7.2 0.343
  PASP (mm Hg) 31.1±5.7 30.8±5.6 32.1±7.7 0.794
  TAPSE/PASP (mm/mm Hg) 0.84 (0.71–0.98) 0.84 (0.68–1.00) 0.76 (0.64–0.94) 0.003 0.985 <0.001 0.005
Pulmonary function
  FEV1 (L) 3.1±0.8 3.1±0.8 2.9±0.8 <0.001 1.000 <0.001 0.001
  FVC (L) 3.9±1.0 4.0±1.0 3.8±1.0 0.006 1.000 0.019 0.007
  FEV1/FVC 0.80 (0.76–0.84) 0.78 (0.75–0.82) 0.78 (0.73–0.82) <0.001 <0.001 <0.001 0.255
CAC score (>0 AU) 24% 30% 41% <0.001
Continuous variables are expressed as mean±SD if normally distributed and as median (IQR) if non- normally distributed; categorical variables 
are reported as counts (%).
*Test for trend for continuous variables, and χ2 test for categorical variables.
†Student t- test or Wilcoxon rank- sum test.
AU, Agatston unit; C, current; CAC, coronary artery calcium; E/e', Ratio of pulsed- Doppler derived E- wave from mitral inflow to tissue- 
Doppler derived left ventricular lateral e'; F, former; FEV1, forced expiratory volume in one second; FVC, forced vital capacity; HDL, high- 
density lipoprotein; LA, left atrial; LV, left ventricular; N, never; PASP, pulmonary artery systolic pressure; RVe', right ventricular early diastolic 
velocity; RVS', right ventricular peak systolic velocity; TAPSE, tricuspid annular plane systolic excursion.
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Table 2 Linear regression analyses for the association of smoking status with RV systolic function assessed by tricuspid 
annular peak systolic velocity (RVS')
Univariate Model 1
β SE P value β SE P value
Smoking status
Never (ref.) Ref. Ref. Ref. Ref. Ref. Ref.
Former −0.033 0.111 0.768 −0.114 0.130 0.383
Current −0.263 0.122 0.031 −0.343 0.156 0.028
β=coefficient; model 1: adjusted for age, sex, race, years of education, body mass index, systolic blood pressure, use of antihypertensive 
medication, total cholesterol, high- density lipoprotein cholesterol, use of lipid- lowering medication, forced expiratory volume in one second, 
left ventricular ejection fraction, pulsed- Doppler derived mitral E- wave/tissue- Doppler derived left ventricular lateral e’ ratio and coronary 
artery calcium score.
ref., reference; RV, right ventricular; RVS', right ventricular peak systolic velocity.
Table 3 Linear regression analyses for the association 
of smoking status with RV systolic function assessed by 
tricuspid annular plane systolic excursion (TAPSE)
Univariate Model 1
β SE
P 
value β SE
P 
value
Smoking status
  Never (ref.) Ref. Ref. Ref. Ref. Ref. Ref.
  Former 0.005 0.023 0.819 −0.023 0.026 0.376
  Current −0.115 0.025 <0.001 −0.082 0.031 0.008
β=coefficient; model 1: adjusted for age, sex, race, years of 
education, body mass index, systolic blood pressure, use of 
antihypertensive medication, total cholesterol, high- density 
lipoprotein cholesterol, use of lipid- lowering medication and forced 
expiratory volume in one second, left ventricular ejection fraction, 
pulsed- Doppler dervied mitral E- wave/tissue- Doppler derived left 
ventricular lateral e’ ratio and coronary artery calcium score.
ref., reference; RV, right ventricular.
more than 33 years. Those in the third smoking duration 
tertile had worse TAPSE in comparison with those in the 
first tertile (β=−0.116, SE=0.051, p=0.024) in the univar-
iate analysis, although this relationship was not signifi-
cant in the fully adjusted model 1 (online supplementary 
table 4). Neither RVS’ nor RVE’ were different among 
smoking duration tertiles. Neither systolic nor diastolic 
RV functions were significantly related to smoking inten-
sity or cigarette pack- years (online supplementary tables 
5 and 6).
dIsCussIOn
Since the initial reports warning the harmful effects of 
tobacco use, many investigations have studied the associ-
ation of cigarette consumption with CVD, usually seeking 
conditions affecting the left ventricle.1 By contrast, our 
study is focused on the relationship between smoking 
and the right ventricle, performed in a large multicenter 
community- based biracial cohort of middle- aged individ-
uals. Our findings demonstrate that smoking is associated 
with both worse RV systolic and diastolic function.
In our study, current smokers had worse RV systolic 
function than those who never smoked, independent 
of demographics, concurrent traditional cardiovascular 
risk factors, pulmonary function measured 5 years earlier, 
LV systolic and diastolic functions, and CAC score. In 
another large study from the Multi- Ethnic Study of 
Atherosclerosis (MESA), current smokers had both lower 
RV mass and lower RV volume as assessed by MRI.13 In 
contrast, smoking status was not associated with RV struc-
ture and function as examined by echocardiography in 
the Atherosclerotic Risk in Communities (ARIC) study. 
Of note, in the ARIC study, participants were elderly 
(mean age of 75.8±5.1 years); only 6.3% (n=287) were 
smokers; and many with smoking related events may have 
died before study analysis.14 In this present analysis of 
the CARDIA year 25 examination, participants were at 
middle age (50±4 years), and 17% (n=589) were current 
smokers.
We also demonstrated that not only current smokers 
but also former smokers had worse RV diastolic func-
tion compared with never smokers. Prior investigation 
has reported an acute effect of cigarette smoking on RV 
diastolic function as assessed by echocardiography.15 16 
Smoking a single cigarette can rapidly lead to oxidative 
damage of endothelial cells, increases in heart rate and 
blood pressure, and coronary vasoconstriction.17 These 
acute changes in cardiovascular function might explain, 
at least in part, the association of current smoker status 
with worse RV diastolic function showed in our study. 
Nonetheless, according to our findings, former smokers 
also had worse RV diastolic function in comparison with 
never smokers, which may suggest a role of persistent 
harmful effects of smoking on the right ventricle. Interest-
ingly, RV systolic function was not significantly different 
in these two groups, suggesting that different pathways 
may link smoking with RV systolic and diastolic function. 
Further research is required to examine differences in 
pathophysiological mechanisms on RV impairment asso-
ciated with smoking.
In an exploratory analysis, we examined three compo-
nents of smoking exposure in current smokers: inten-
sity, duration and pack- years (product of intensity and 
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Table 4 Linear regression analyses for the association of smoking status with RV diastolic function assessed by early 
diastolic tricuspid annular tissue velocity (RVE’)
Univariate Model 1
β SE P value β SE P value
Smoking status
  Never (ref.) Ref. Ref. Ref. Ref. Ref. Ref.
  Former −0.371 0.140 0.008 −0.414 0.162 0.011
  Current −0.847 0.155 <0.001 −0.715 0.195 <0.001
β=coefficient; model 1: adjusted for age, sex, race, years of education, body mass index, systolic blood pressure, use of antihypertensive 
medication, total cholesterol, high- density lipoprotein cholesterol, use of lipid- lowering medication and forced expiratory volume in one 
second, left ventricular ejection fraction, pulsed- Doppler derived mitral E- wave/tissue- Doppler derived left ventricular lateral e’ ratio and 
coronary artery calcium score.
RV, right ventricular; RVS', right ventricular peak systolic velocity.
duration). Our results showed that longer duration of 
continuous smoking might be related to worse RV systolic 
function, as evaluated by TAPSE. However, this result 
was inconsistent when RV systolic function was assessed 
by RVS’, which was not related to duration of smoking. 
Furthermore, the relationship between lower TAPSE and 
worse RV systolic function was not statistically significant 
in the multivariable model. No relationship between 
intensity and pack- years with RV systolic and diastolic 
function was found. A recent investigation from the 
MESA study found that smoking duration was not asso-
ciated with CVD, while smoking intensity was a stronger 
correlate of CVD outcomes.18 Such diverse results might 
be explained by different pathophysiological pathways 
linking smoking to RV dysfunction compared with those 
related to smoking and other CVD. Also, smoking inten-
sity and duration may vary over time, which may lead to 
imprecise measurements in self- reported questionnaires.
Although pulmonary vascular remodelling is usually 
present in patients with advanced COPD, it can also 
occur in those with mild COPD and even in smokers 
with normal lung function.19 20 Furthermore, RV systolic 
function, hypertrophy and dilation can be found in those 
with mild COPD and normal pulmonary artery pressure, 
suggesting early RV impairment in the course of pulmo-
nary vascular disease.21 The association of smoking with 
worse LV diastolic function and higher LV mass has been 
previously demonstrated.14 LV filling pressures can plau-
sibly affect RV function through backward transmission 
toward the pulmonary vasculature. Moreover, decrease of 
coronary blood flow and systemic inflammatory response 
might also play a role in the relationship between smoking 
and RV dysfunction.22 23 In an experimental model, 
mice exposed to cigarette smoking showed significantly 
reduced RV systolic function, as examined by TAPSE, 
with no changes in either LV parameters or pulmonary 
vasculature, but with increased cardiac fibroblast prolif-
eration and collagen content in the right ventricle.24 
Interestingly, nicotine alone reproduced these effects 
in that study. However, further studies are needed to 
better elucidate the role of those intermediate factors as 
significant mediators on the association of tobacco use 
and RV impairment.
limitations
Echocardiography is a useful diagnostic tool for exam-
ining RV function.25 This study used M- mode- derived 
TAPSE and tissue Doppler- derived RVS’ as measures of 
RV systolic function. Both parameters are frequently 
used in clinical practice, although RV strain from speckle 
tracking analysis has been considered as a more sensitive 
index of RV myocardial dysfunction. Unfortunately, RV 
strain was not available at CARDIA year 25. Unfortunately, 
in the CARDIA year 25 examination, reproducibility of 
RV indices was not performed. Nevertheless, echocar-
diographic exams followed a standardised acquisition 
protocol, whose manual of operation is available online 
(https://www. cardia. dopm. uab. edu), and all technicians 
at each of the four field centres were centrally trained 
and certified. Also, TAPSE and RVS’ are easy to perform, 
with very low inter- reader and intrareader observer vari-
ability, as demonstrated elsewhere.26 The present study 
has a cross- sectional design; hence, conclusions about 
temporality or causal associations cannot be made. 
Pulmonary function data were not available at the time 
of the year 25 examination. Since pulmonary function 
was used only as one as multiple confounding variable, it 
is unlikely that the main associations we observed would 
have changed if we had used year 25 data on pulmonary 
function data instead. Although the effect size of the rela-
tionship between smoking status and RV function seems 
not to be high, small effect sizes are not unexpected in 
relatively healthy young adults, and, importantly, the 
public health importance is in mitigating the delete-
rious changes before they become irreversible. However, 
we recognise that how much these subtle changes in 
RV function influence risk of heart failure is unknown 
and should be subject of further research. We recog-
nise that LV dysfunction, pulmonary hypertension, and 
inflammation are potential mediators in the relationship 
between smoking status and RV function. However, the 
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cross- sectional design of this present study precludes a 
reliable mediation analysis, which would be performed 
in further longitudinal studies.
Clinical perspectives
Recently, the role of the right ventricle in a spectrum of 
CVDs has gained renewed attention.27 Nevertheless, few 
studies have addressed the association of smoking and 
RV adverse remodelling.13–16 28 In this large population- 
based cohort of individuals at middle age, our findings 
show a relationship between cigarette smoking status 
and RV systolic and diastolic functions, independent of 
demographics, traditional cardiovascular risk factors and 
pulmonary function. Such findings advance knowledge 
about the harmful effects of tobacco use on the cardio-
pulmonary unit, and suggest a direct effect of smoking 
on RV function. Furthermore, our findings support 
the hypothesis of a potential role of RV impairment for 
predicting adverse events in smokers.
COnClusIOns
In a large multicenter community- based biracial cohort 
of middle- aged individuals, smoking was related to 
reduced RV systolic and diastolic functions, independent 
of demographics, traditional cardiovascular risk factors 
and pulmonary function.
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